People · Operator
Named in public records as an officer, director or promoter · active 2011–2025 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Neurona Therapeutics, Inc | — | Biotechnology | Series D+ | $347.5M | $875.0M | 2014 |
| Surrozen, Inc. | — | Biotechnology | Series C | $50.0M | $2.0B | 2020 |
| Kallyope, Inc. | — | Biotechnology | Series B | $28.1M | $1.1B | 2015 |
| Peloton Therapeutics, Inc. | — | Biotechnology | Series A | $13.7M | $423.0M | 2011 |
| NILO Therapeutics, Inc. | — | Biotechnology | Series A | $9.6M | $49.3M | 2024 |
| Site Tx, Inc. | — | Other Health Care | Series A | $6.0M | $31.7M | 2024 |
| Cyterix Pharmaceuticals Inc. | — | Biotechnology | Seed | $2.4M | $66.6M | 2011 |
Tim Kutzkey at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Tim Kutzkey on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Goeddel | 3 | 10 |
| Michael Brown | 1 | 34 |
| Michael O'Donnell | 1 | 11 |
| Adam Goulburn | 1 | 10 |
| Terry McGuire | 1 | 8 |
| John Creecy | 1 | 5 |
| Craig Parker | 1 | 5 |
| Peter Svennilson | 1 | 4 |
| Leo - Guthart | 1 | 4 |
| William Rieflin | 1 | 4 |
| Jeff Goater | 1 | 4 |
| Joshua Wolfe | 1 | 4 |
| Erica Whittaker | 1 | 3 |
| Robert Tjian | 1 | 3 |
| John Josey | 1 | 3 |
| Kenneth Clark | 1 | 3 |
| James Stutz | 1 | 2 |
| Brad Margus | 1 | 2 |
| Brett RIngle | 1 | 2 |
| Nancy Thornberry | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.